Slashdot Mirror


The Next Revolution In Medicine: Genome Scans For Everyone

the_newsbeagle writes "This year, a biotech company called Ion Torrent will introduce a new chip for its genome sequencing machine, which should enable researchers and doctors to scan a complete human genome for $1000 and in just a couple of hours. Compare that to the effort required to complete the first human genome: $3 billion and 13 years. Ion Torrent has nearly reached the $1000-genome milestone by virtue of a process called 'semiconductor sequencing,' and the company's founder says his chip-based sequencing machine benefits from all the efficiencies of the computer industry. At a price point of $1000, genome scans could become a routine part of medicine. And the price could keep dropping. To test out the technology, and to investigate just how useful genome scans are these days for your typical, reasonably healthy person, the IEEE Spectrum reporter got her own genome scanned and analyzed."

26 of 126 comments (clear)

  1. Just hold on a minute there, cowboy. by ColdWetDog · · Score: 5, Insightful

    Price isn't the only determinant of whether something is a 'routine part of medicine'. For the foreseeable future, there is remarkably little utility that an individual's genome brings to the table. It will become a very important part of medical research, but in terms of an individual's health, not so much.

    It will be hyped. It will likely end up like 'full body CT scans" - a bragging tool for the seriously hypochondriac but of no help to the routine patient.

    Even the Single Nucleotide Polymorphism (SNP) data which is pretty cheap now (basically what the police use for forensics) helps most people very little. In the context of answering a specific genetic question, perhaps - but not as a routine. When you send someone to a medical geneticist, most of the time and effort revolves around getting the person to understand what you are trying to accomplish and the pros and cons of doing so. Having whole genome sequencing just makes it even harder.

    --
    Faster! Faster! Faster would be better!
    1. Re:Just hold on a minute there, cowboy. by pesho · · Score: 5, Insightful

      Price isn't the only determinant of whether something is a 'routine part of medicine'.

      yes it is, do you know how much money your doctor can make by adding this to your routine blood work?

    2. Re:Just hold on a minute there, cowboy. by ColdWetDog · · Score: 2

      First off, insurance companies in the US are already barred from using genetic data for insurability purposes.

      Second, straight DNA sequencing doesnt give you the keys to the kingdom. Epigenetic factors like methylation are turning out to be extremely important factors in gene expression. Further, there are a number of classes of RNAs that are likewise critical to organism development.

      Basically, the central dogma has been barking up the wrong tree.

      --
      Faster! Faster! Faster would be better!
    3. Re:Just hold on a minute there, cowboy. by drinkypoo · · Score: 4, Interesting

      For the foreseeable future, there is remarkably little utility that an individual's genome brings to the table.

      That's true as long as you treat humans like poor people treat cars and fix them when they break, but it's not true if you treat humans like rich people treat cars and take them in (or have them taken in) for all their scheduled maintenance.

      --
      "You're right," Fisheye says. "I should have set it on 'whip' or 'chop.'"
    4. Re:Just hold on a minute there, cowboy. by K.+S.+Kyosuke · · Score: 2

      As a diagnostic tool it would be invaluable. Supposing a patient presents with the symptoms for say Celiac. Assuming a genetic test exists you can sample a drop of blood rather than perform a biopsy of the colon to confirm the diagnosis.

      Not only that, what happens if you do large-scale sequencing of human population and correlate their medical records with their genetic makeup, and apply some serious machine learning? I smell large health care expenses savings ahead...

      --
      Ezekiel 23:20
    5. Re:Just hold on a minute there, cowboy. by Artraze · · Score: 2

      > Price isn't the only determinant of whether something is a 'routine part of medicine'. For the foreseeable future,
      > there is remarkably little utility that an individual's genome brings to the table.

      Technically, yes, it's not so much price and it is value, but realistically price is still a major factor in that calculation.

      As it stands, there are quite a few diseases that we can identify just looking at the genome. For many, sure, there are other tests, but if genome screening was, say, cheaper than two of those, then it would be a significant and valuable first stop for both diagnostic and preventative medicine.

      (And of course, the cheaper it becomes, the more analysis can be done and the more useful it becomes.)

    6. Re:Just hold on a minute there, cowboy. by Grave · · Score: 2

      Along with making the entire insurance industry freak out. If you can know, from birth, the statistical likelihood of ending up with a disease, that suddenly does some interesting things to health care premium calculations. Does the requirement that you cannot be denied coverage due to pre-existing conditions have any restriction over individual premiums?

    7. Re:Just hold on a minute there, cowboy. by Fwipp · · Score: 2

      Because if I have a 40% chance of getting leukemia, my insurance premiums will be through the roof. So even if I never got leukemia, I would have spent significantly more than Jane down the street.

      (Really, this just continues to argue against private insurance and health care. But having expected/mandatory genetic tests will punish some individuals for things they have no control over.)

  2. will make a mockery of preexisting conditions by Trepidity · · Score: 2

    Either:

    1. Using this data for insurance purposes will be banned, which turns "preexisting condition" into a criterion that can only be applied with eyes closed;

    or 2. Huge numbers of people will be uninsurable, because the likelihood of their future illnesses will be known before they try to buy insurance.

    1. Re:will make a mockery of preexisting conditions by ADRA · · Score: 5, Insightful

      It works great for countries where health is 'free' (through taxes), and their main goal is to make people healthy, not to extract maximum funds from your pocket. It's too bad that you don't live there.

      --
      Bye!
    2. Re:will make a mockery of preexisting conditions by Trepidity · · Score: 2

      From an actuarial point of view, it's a reasonable comparison. The difference is that people are born in one body with a lot of things that they can't really do anything about. Sort of like being born in a burnt-down house without any possibility to move to a new one.

      A conclusion could be that insurance for healthcare makes no sense. How do I insure against the possibility of being born with a genetically caused condition? I'd have to buy insurance before I was born.

    3. Re:will make a mockery of preexisting conditions by Trepidity · · Score: 2

      I disagree. I think if some people have the misfortune to be born with worse genes, they shouldn't have the double misfortune of also having a significant financial burden piled on top of other burdens such as needing to get surgery. I wasn't born with a congenital heart defect, for example, but that was pure luck, not something I "deserve", and I'm perfectly happy to pay my fair share towards treating those who were less fortunate in their birth.

  3. Doubt it by ceoyoyo · · Score: 2

    Very few diseases are due to simple genetic factors, and those already have dedicated tests. Genotyping may eventually become a big part of medicine, but not until there is a LOT more research done into how to use it, a lot more data available, and a lot better techniques for using it.

  4. Wait 'til the insurance companies get this ... by gstoddart · · Score: 2, Funny

    Of course, one of the immediate things people will need to worry about is misuse of this. One can easily see the insurance companies making everybody take one of these, and then refusing you coverage based on your genetics.

    These kinds of things can have unintended consequences pretty quickly, and the privacy and legal implications of these kinds of tests cheap and routine haven't all been worked out.

    I can certainly see all sorts of potential for abuse of this. I wouldn't be eager to sign up for this, but, I do tend to the tinfoil hat end of the spectrum on these things.

    --
    Lost at C:>. Found at C.
    1. Re:Wait 'til the insurance companies get this ... by compro01 · · Score: 2

      One can easily see the insurance companies making everybody take one of these, and then refusing you coverage based on your genetics./quote>

      That base is already covered, at least in theory. The Genetic Information Nondiscrimination Act was passed in 2008 to deal with that.

      --
      upon the advice of my lawyer, i have no sig at this time
  5. Not just health by symes · · Score: 4, Funny

    It would be neat to have a nice, light and portable genome sequencer for when I next go eating meat in the UK

    1. Re:Not just health by Anonymous Coward · · Score: 2, Funny

      It would be neat to have a nice, light and portable genome sequencer for when I next go eating meat in the UK

      I for one would appreciate some serious commentary on the article versus just horsing around.

  6. I worked at a DNA sequencing company for 5 years by volvox_voxel · · Score: 5, Interesting
    Sequencing has enabled all sorts of medical diagnostics and research that were previously unavailable. It was quite exhilarating to to read in Journals like Nature about people that had late stage cancer being sequenced to find out that they were misdiagnosed with the wrong cancer. Just a few years ago, it was impossible to determine what type of cancer a cancer was before it spread. Once it has metastasized, it was all a guessing game. With sequencing you can know for sure, and give you the right medicine to address that cancer.

    I've always considered biology to be hundreds of years behind physics and the other "hard sciences", because they never had the tools to deal with it.The CPU power, the RAM, the hard-disk space, even the cloud infrastructure are all needed to make DNA sequencer efficient. The last instrument I worked on was a low cost DNA sequencer that could yield a sequence in one day. At the end of a run, to do the basecalling and base alignment of the data, you would need significantly more horsepower than what was on the meager instrument. The cloud allows you access to a supercomputer the the short time that you need it, so the customer is not burdened by the huge computational complexity involved.

    As the cost sequence drops (and continues to drop), whole new fields of research have opened up. Bioinformatics where biology and computer science meet is a pretty hot topic. We have a deluge of data, but we don't yet have all the good algorithms necessary to unlock all the secrets we wish to solve. The Rosetta stone of the 21st century. This is the biggest complaint I hear about from biochemists.. Making sense of the data. Data leads to knowledge leads to wisdom, but data is not knowledge.

    I consider DNA sequencing to be an enabler, just like the steam-engine, or the electric light. It is now possible to look deeply at things we never could, like meta-genomics. Did you know that you have more bacteria in your body then all other cells in your body put together? ..And did you know that you can't grow most of them on a petri dish? We have been to mars, but we don't even know the bacteria in our own gut. Meta-genomics is a form of "shot-gun sequencing" .. In the lab you understand the biology by making millions of replicas of it in the petri dish.Not all bacteria grow on a petri-dsh . With shot-gun sequencing, you sequence enough sample so you can digitally reconstruct what organisms were there to begin with. This has enabled us to [begin to] understand the biochemical messaging between soil bacteria and the roots of plants, understand the biochemistry of food digestion to generate bio-fuels more efficiently, etc .. Interesting times...

  7. Sequence once, analyze later by Kjella · · Score: 2

    Since your genetic markup doesn't change (except for stray mutations but AFAIK not that spread to every cell in your body - single sperm cells are different) the question is can you pay off $1000 over your whole life and medical history? With every advance likely to come 10-50 years down the road? A quick search came up with this from Employer Health Benefits 2012 Annual Survey: The average premium for single coverage in 2012 is $468 per month or $5,615 per year. So over 70 years (probably some of them on a family plan, offset by paying for a family plan) you're likely to spend $400k on health plans.

    That means you have to improve efficiency by 0.25%, either by simple prevention, earlier detection, finding the right diagnosis earlier, better treatment before we get to all the possibilities of genetic medicine and it will pay off. Not in the US of course, where they'll drop you like a hot potato and/or pocket the savings themselves, but in other countries with universal healthcare lifetime costs are on the same order. I just did the math here in Norway and to DNA sequence everyone would be 25-30% of one year's healthcare budget. If I divide by an average lifespan of about 80 then about 0.33% of the healthcare of a lifespan. That doesn't sound like an unreachable goal to me.

    --
    Live today, because you never know what tomorrow brings
  8. Re:Pretty little by Tarsir · · Score: 2

    $1000 is what it will cost the hospital. You'll see a $10,000 charge on your bill.

  9. IonTorrent? LOL. by Cyberax · · Score: 2

    IonTorrent has been promising wonderful new machines _just_ next quarter for almost two years now. So far, they have delivered only a few machines to select customers under NDAs. And they still haven't solved a couple of crippling problems: homopolymer resolution and fairly short read length.

    Also, they haven't showed anything on this year's AGBT (it's like CES, only for biotech) last week. So I won't be holding my breath waiting for $1k genome sequencing machines.

    1. Re:IonTorrent? LOL. by volvox_voxel · · Score: 2
      It's interesting that Ion Torrent has been getting so much more media exposure than Illumina, the market leader. By all accounts, from actual users, the data quality is better. Getting low error rates may involve much more sampling. This is very much akin to the bit error-rate probability in digital communication, and the number of packets you need to transmit to reduce the error to acceptable levels (but in this case, there is no forward error correction).

      Illumina uses fluorescent labeling which has a much better inherent signal-to-noise ratio than sensing-pH where you have to deal with surface effects from the wells, not to mention the homopolymer issues inherent to their chemistry..

      The one allure that ion-torrent has, is that it doesn't involve any optics, and thus can potentially be made much cheaper (how cheap it is depends on their error rates though). I know that there are several companies that are trying to make sequencing cheaper. There is a lot of interesting work being done in the sequencing world. The top of the line DNA sequencer from 2010 was equivalent to 60,000 top-of the line instruments from 2006. The progress is currently beating moore's law.

  10. Re:I worked at a DNA sequencing company for 5 year by CptNerd · · Score: 3, Insightful

    Data -> information -> knowledge -> wisdom

    There are also non-gene mechanisms that need to be understood as well, since the genome is a blueprint, but what happens when the cell actually starts using that blueprint? Anyone who's had a house built knows that it's the contractors that actually make the house, not the architect, and there are an unknown number of contractors inside individual cells that control what gets built. What makes a particular cell use the "retina" part of the blueprint, and another cell use the "heart muscle" part? I don't believe we know all the answers outside the genome, yet. All those cellular contractors and we don't understand their language (yet).

    --
    By the taping of my glasses, something geeky this way passes
  11. Re:Pretty little by witherstaff · · Score: 2

    Only 10X the cost? The latest Time magazine was devoted to Health Care in the US. Most of it was bringing to light the huge overbillings done for nearly everything. We'd probably see a 25x or 50x cost to this.

  12. Re:Pretty little by ChumpusRex2003 · · Score: 3, Interesting

    Well, it's $1000 for the consumables for the device, and the operator's time. Then there's the cost of the machine, building, admin, etc.

    In reality though, this is extraordinarily cheaper than what is done at present. Currently, if a physician suspects a genetic disorder, then they the typical process used in a medical genomics laboratory is to use a "matching" technique where the patient's DNA is matched to known mutations. Typically, this costs around $500-700 per mutation tested against. For a number of diseases, this only gives a 75-80% accuracy, because certain genes are prone to new spontaneous random mutations, and have a lot of "normal" functioning variants - so simply checking for a known good gene isn't an option. As a result, these patients end up only with a presumptive diagnosis, leading to difficulties in family and reproductive counselling (i.e. do siblings need to be aware of the risk of passing on a genetic disorder to their offspring?)

    Sequencing is occasionally performed in patients with unknown presumed genetic diseases, where a suspected gene is known - but the cost is very high, and it is infrequently done, unless a whole family are affected, and it is possible to identify which the culprit gene is likely to be.

    Total genome sequencing, while not a panacea, would greatly help the diagnosis and research into newly recognised, presumed genetic diseases. If the total cost of the testing can be brought down to $2000 per analysis, then that would be cheap compared to the current techniques for genetic diagnosis.

    Finally, as to the MRI - the actual cost of an MRI scan including scanner, building, maintenance, staff, admin is about $300-600 depending on scan complexity (or at least, that's the "bulk" price charged by private MRI facilities to insurers or hospitals who have exceeded the capacity of their own MRI scanners).

  13. Re:I worked at a DNA sequencing company for 5 year by aaronb1138 · · Score: 4, Interesting

    I have generally considered biology so far behind the other hard sciences, especially physics, precisely because for a very long time they failed to consult with the chemists, physicists, and engineers. It has largely been self-induced, and almost entirely a process of falling behind. Heck we have some hacks out there in biology using morphological databases (today - with all the genetic tools they have!) to reverse engineer evolution, when the biologists are well aware that morphology is a good categorizing and search tool (it tells you where to start genetically looking), not an extrapolation tool for real data and conclusions.

    Physics in particular finally just started going the route of butting in wherever they figured out they could be useful to biologists and clinicians especially. CT and MRI are great examples.

    Rothberg's own 6 years of research to sequence 9000 letters of genetic code is a perfect example. After a year or so, a physicist or engineer would have said f--- this, there must be some way of automating this process. I suspect most of the scientists at Ion Torrent are chemists, EEs, and physicists. Probably not too many pure biologists (though some biophysicists are probably around).